Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page
- Check3 days agoChange DetectedRemoved the government funding status notice; study details and links remain unchanged.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedNon-significant changes observed: The two screenshots show largely the same Study Details page with no core information added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check46 days agoChange DetectedUpdated to v3.2.0 with an operational status notice; removed a specific disease resource (Cutaneous neuroendocrine carcinoma) and v3.1.0 reference.SummaryDifference4%

- Check53 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1, indicating a new release. The 'Back to Top' element was removed; otherwise, there are no changes to core content, pricing, stock, or time-sensitive information.SummaryDifference0.2%

- Check74 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.